Company Overview

Update
Founded:
2006
Founders:
Hans-Reiner Figulla
Headquarters:
München
Funding:
$86M
Categories:
Hardware + Software
Description:
JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.

Detailed Description

Update

JenaValve's device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation. At a very early state, it became clear to their research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

Current Team (7)

Update

Past Team (1)

Update

Board Members and Advisors (7)

Update

Investors (10)

Update

Offices/Locations (2)

Update
  • US Holding

    1000 N. West Street

    Suite 1200

    Wilmington, DE 19801

    USA

  • European Headquarters

    Guerickestraße 25

    München, 80805

    DEU

Images (2)

Update
  • Mhfdhavjglso8u8oreco
  • 53f1d7ee30c933b89055e36ba28ae821